Glycaemia and correlates of patient-reported outcomes in ACCORD trial participants

Autor: Fran Ganz-Lord, Mark D. Sullivan, K. M. V. Narayan, Mohammed K. Ali, Patrick J. O'Connor, David C. Goff, Pan Zhang, Roger T. Anderson, Patricia Feeney, Debra L. Simmons, Don Hire
Rok vydání: 2012
Předmět:
Zdroj: Diabetic Medicine. 29:e67-e74
ISSN: 0742-3071
DOI: 10.1111/j.1464-5491.2011.03532.x
Popis: Diabet. Med. 29, e67–e74 (2012) Abstract Aims Post-hoc evaluation of relationships between first-year change in glycaemic control (HbA1c) and change in patient-reported outcomes among ACCORD health-related quality of life (HRQoL) substudy participants. Methods Data from 2053 glycaemia-trial subjects were analysed. We assessed physical and mental health status (36-Item Short Form Health Survey, Version-2), symptom count and severity (Diabetes Symptoms Distress Checklist) and treatment satisfaction (Diabetes Treatment Satisfaction Questionnaire). Linear mixed models were used to test relationships between 1-year changes in HbA1c and patient reported outcomes sequentially adjusting for correlates (baseline characteristics, baseline patient reported outcomes, treatment assignment, frequency of clinical contact and post-randomization weight change plus new complications). Results Poorer baseline control of HbA1c and cardiovascular disease risk factors predicted greater one-year improvements in treatment satisfaction. Similarly, poorer baseline patient reported outcome scores all individually predicted greater 1-year improvement in that same outcome. Accounting for baseline and post-randomization characteristics and treatment arm, 1-year change in HbA1c was unrelated to changes in overall physical or mental health; however, every one percentage-point (10.9 mmol/mol) reduction in HbA1c was associated with lower symptom count (β = 0.599; P = 0.012), lower symptom distress (β = 0.051; P = 0.001), and higher treatment satisfaction (β = −2.514; P
Databáze: OpenAIRE